Tool Create startup animated videos in minutes, not in hours! 

Dren Bio Announces a $60M Series A

Dren Bio Announces a $60M Series A Back to HomeSAN CARLOS, CA, Dren Bio announced the closing of a $60 million Series A investment round led by SR One and Taiho Ventures. Dren Bio, Inc., a company developing powerful protein-engineering technologies for depletion of cells, protein aggregates and other disease-causing agents, announced the closing of a $60 million Series A investment round. Dren Bio is a biotechnology company developing powerful protein engineering technologies to deplete cells, protein aggregates and other disease-causing agents. Dren is actively working in other areas including auto-immune disorders and diseases of protein aggregation. Dren's team includes accomplished research and development personnel with strong collective industry experience.

Startup Around is now on Telegram and Whatsapp. For the best startup stories & resources, subscribe us on Telegram & Whatsapp.
Get the best stories from Startup Around on Telegram